Krüger-Franke M, Pförringer W, Strasser R, Klauser R J
Staatliche Orthopädische Klinik, München.
Z Rheumatol. 1991 Sep-Oct;50(5):323-7.
High-performance liquid chromatography of collagen degradation products in human urine for diagnosis of osteoarthrosis was introduced by Macek and Adam (6) in 1987. The aim of the present study was to demonstrate the clinical usefulness of this method in a group of 20 patients with osteoarthrosis of the hip and 10 healthy volunteers. There were no significant differences in number or intensity of the detected signals between the two groups. The results of this study show that the determination of collagen degradation products is not useful for diagnosis or for the control of therapy in patients with osteoarthrosis.
1987年,马塞克和亚当(6)介绍了用于诊断骨关节炎的人尿中胶原蛋白降解产物的高效液相色谱法。本研究的目的是证明该方法在一组20例髋骨关节炎患者和10名健康志愿者中的临床实用性。两组之间检测信号的数量或强度没有显著差异。这项研究的结果表明,胶原蛋白降解产物的测定对骨关节炎患者的诊断或治疗控制没有用处。